Neurology is inherently patient-centered given that clinical uncertainty is common, forcing physicians, patients, and families to partner on treatment approach. An increasing emphasis on patientcentered care, patient engagement, and shared decision-making (SDM) in health care provides neurologists with an opportunity to reassess current clinical approaches to decision-making. Such assessment is not simply theoretical but has clear practice implications, with patients indicating a desire for SDM and calls for reimbursement to be tied to demonstration of SDM in practice. We present a framework for how neurologists enhance patient-centered practice by (1) eliciting patients' values and goals, (2) targeting discussion of clinical options to those values and goals, and (3) partnering with patients to make individualized decisions. We also highlight resources that facilitate SDM and examples of SDM in neurology clinical practice. Neurol Clin Pract 2016;6:190-197 P atient-centered care, patient engagement, and shared decision-making (SDM) are increasingly referenced terms in medical literature and lay health care discussions. We discuss patient-centered concepts relating to neurology outpatient settings.
While research to date fails to demonstrate a clear effect of SDM on health outcomes, 3 the foundations underpinning patient-centered care and SDM are more ethical ones, emphasizing the principles of autonomy and self-determination and the importance of patients achieving these ideals with physician assistance. Autonomy and self-determination have particular weight in neurology, where clinical uncertainty is common. There is rarely a right answer for neurologic decisions, emphasizing the importance of patients choosing the best option based on individual values and goals. For example, patients with multiple sclerosis and their physicians now have treatment options with considerations to weigh beyond efficacy, e.g., mechanism of administration, cost, and side effect profile. The value that individuals place on these considerations will differ.
Beyond the ethical mandate, there are practical reasons to perform SDM. Research suggests that most patients want to actively participate in decision-making. 4, 5 SDM is also highlighted in the Affordable Care Act, which mandates programs to develop, evaluate, and disseminate decision aids (DAs) that enhance SDM. Some propose that the Centers for Medicare and Medicaid Services certify and implement DAs and tie reimbursement to use of these DAs and SDM documentation. 6 DAs are tools that (1) state the decision, (2) provide evidence about potential benefits, harms, and probabilities associated with different options, and (3) guide individuals through recognizing values that inform the decision. 7 DAs are not stand-alone patient tools, but rather provide a framework for physicians to guide patients through decisionmaking. A Cochrane review found that DAs increased knowledge, lowered patients' decisional conflict stemming from feeling uniformed, reduced patient passivity in decision-making and the number of patients unable to decide, and resulted in more decisions for less aggressive care. 7 General studies of patient-centered care and SDM show positive benefits on knowledge, satisfaction, and self-management with mixed results for clinical outcomes. 3, 8 Patient engagement in neurologic clinical practice In our model for patient engagement in clinical visits (figure), each participant has a role in addressing the steps of SDM.
Role of the physician The framework includes 3 steps requiring physician action, similar to other models. 9 Step 1: Physicians solicit patients' values and goals. While SDM literature often focuses on the interplay between physicians and patients addressing pros and cons of health care decisions, SDM is likely best achieved when physicians know a patient's values and goals and frame decisions in that context (table 1). Step 2: Physicians present the evidence behind health care decisions as it relates to the patient's values/goals. Physicians help patients understand how an intervention may help them achieve their goals (e.g., through symptom treatment) or how it might put goals at risk (e.g., through side effects). Step 3: Patients and physicians reach a final decision based on discussions of evidence alongside patients' values/goals.
Role of the patient Patients provide personal values and goals, informing the evidencebased discussions (step 1). They listen to options and related pros and cons presented by physicians (step 2). Ultimately, patients make the best decision for their personal situation Patient engagement describes meaningful patient involvement in different aspects of care including research, guideline development, and clinical encounters.
Neurology.org/cp (step 3). While not all patients desire to fully engage at each step-discussed further below-most patients desire SDM. 4, 5 Role of the carepartner/caregiver Both carepartners-family members or friends partnering in care based on existing relationship (e.g., marriage) without implying a need for assistance-and caregivers-individuals who provide assistance because of a patient's physical or cognitive limitations-have SDM roles. Patients and carepartners may share values and goals (e.g., providing for children, retirement planning) in addition to more patient-specific goals (e.g., improvement in pain) (step 1). Carepartners often have established roles in helping patients weigh pros and cons (step 2) and make major decisions (step 3). Research suggests that individuals with lower education levels may particularly rely on carepartners to assist with SDM. 10 In caregiving, particularly in the context of advanced cognitive impairment, caregivers are the patient's voice. They identify the patient's previously stated goals (step 1), weigh evidence on the patient's behalf (step 2), and suggest what the patient would want if able to decide (step 3).
When patients want physicians to decide Even in studies where patients desire SDM participation, some prefer physicians to make final decisions. 5 Rather than absolving physicians of SDM, however, patient reliance on physician decisions increases the need for solicitation of patients' values and goals. In this way, physicians still successfully engage patients in decision-making. If an older patient wants to remain at home but declines to make a specific clinical decision, the physician might say, "Today we discussed new medicines that could help your symptoms, but likely only a small amount. It sounds like you want keep living alone without help from your children. It might be easier for you to manage on your own if we don't add another medicine. How do you feel about that?" Here the physician engages the patient through eliciting his or her values/goals (independence, living alone 
Case 1
A 55-year-old computer programmer with a 3-year history of tremor and bradykinesia worse on her dominant side has noticed that slowed typing and mouse use has affected her ability to successfully meet work targets. Her husband is at the appointment with her and they are concerned because he has recently lost his job and their children are nearing college age.
Step 1: Solicitation of patients' values/goals Her goal is to work as long as possible to support her family.
Step 2: Discussion of medical evidence for pros and cons of different decisions as informed by patients' values and goals
The medical information in the introduction above is discussed, with particular focus on the medications' variable effect on disability.
Step 3: Making the decision The patient and her husband discuss the pros and cons with the physician. They decide that it makes the most sense for her to start levodopa/carbidopa given its greater effect on disability, hoping that it will improve her typing and mouse skills enough for her to remain employed. The physician also discusses the benefit of the patient and her husband meeting with a financial planner to prepare for different scenarios relating to the husband's employment and the patient's ability to work so that they can plan for college tuition and retirement goals.
Case 2
A 57-year-old salesman feels increasingly slow. He has not told his employer about his diagnosis and is uncertain when he wants to reveal that he has PD.
Step 1: Solicitation of patients' values/goals His goal is to keep his diagnosis private at the present time. He is extremely fearful of developing dyskinesias because he feels this would negatively affect his sales.
The medical information in the introduction above is discussed, with particular focus on the dosing schedules and side effects associated with different medications.
Step 3: Making the decision He chooses to start a once/day form of a dopamine agonist as this allows him to take medication before work and may be associated with a lower risk of dyskinesias in the short term.
Case 3
A 65-year-old physician with a 2-year history of PD has noticed increased tremor and slowness.
Step 1: Solicitation of patients' values/goals He feels he needs symptomatic treatment to allow him to continue to practice. However, he is also very concerned about dyskinesias. He plans on retiring in the next year or two, but has not yet made firm plans for this.
Step 2: Discussion of medical evidence for pros and cons of different decisions as informed by patients' values and goals
The medical information in the introduction above is discussed, with particular discussion about medication effect on disability and recent evidence suggesting dyskinesia onset relates more to PD duration and total levodopa dose than timing of levodopa initiation.
Step 3: Making the decision He decides to start with a dopamine agonist as he is worried about dyskinesias even after discussion of the medical evidence.
Re-evaluation (repeat of steps 1-3 based on new assessment of values/goals)
He notices that he is drowsy every day after his lunch dose and this causes embarrassment in afternoon meetings. He decides to stop the agonist and remain off medicine for now as he plans on retiring soon and feels he can remain untreated until side effects will cause fewer issues.
These cases represent 3 employed patients with PD, each facing the same decision relating to initiation of treatment for PD symptoms. It is only by considering each patient's values (e.g., treating bradykinesia, minimizing medication doses, avoiding dyskinesias, avoiding daytime somnolence) and goals (e.g., working as long as possible, handling symptoms until upcoming retirement) that individualized treatment decisions can be made. By understanding each patient's values and goals, the neurologist can explain how the different treatment options may contribute to those values and goals or how side effects could put them at risk. without assistance) and targets the decision to those values/goals even when the patient declines to make the decision. SDM in the face of clinical certainty With direct-to-consumer advertising and patient Internet research, physicians face requests for tests or treatments in situations where there may be near-certainty that the request is not an appropriate approach (e.g., situations targeted by Choosing Wisely 11 ). Physicians can use SDM to help patients understand why the requested approach does not fit the circumstance and how it will not further stated goals. In some cases, patients' preferences may be at odds with the evidence. SDM is not an easy answer in these challenging situations, but it provides an opportunity for strategies to correct misinformation. 12 Are neurologists practicing SDM? Many physicians perform SDM without calling it by name. A study of rural physicians found that 65% were unfamiliar with the term SDM, but 97% described using that approach. 13 Conversely, one survey reported that 40%-50% of patient respondents indicated a desire for increased involvement in treatment decisions, 14 suggesting that physicians may not be doing as well as they think. This likely reflects the fact that SDM performance is not a "yes" or "no" consideration, but a spectrum where physicians follow the framework to varying degrees.
Resources to facilitate SDM Barriers to SDM include lack of familiarity and experience with SDM, physician and patient attitudes towards SDM, physician knowledge regarding evidence, lack of resources, and time. 15 Health literacy-the skill needed to access, understand, and use information to promote one's health-can also impact SDM, 16 with many individuals lacking understanding of probabilities commonly cited in health care decisions. 17 SDM tools can address some of these barriers such as lack of knowledge, training, resources, time, and health literacy. Lack of time is a commonly described barrier, 18 though the Cochrane review found DA use increased consultation length by a median of only 2.55 minutes 7 and other research showed no increased appointment time from SDM. 18 Option Grids 19 allow physicians to develop personalized SDM outlines for decisions commonly encountered in their own practice. Prefilled Option Grids exist for some neurologic decisions, e.g., regarding surgery for hippocampal sclerosis in temporal lobe epilepsy. 20 Clinical practice guidelines help physicians describe the evidence for different decisions (table 2) . Each American Academy of Neurology (AAN) guideline is accompanied by a patient/family summary that can be shared within SDM, though these are not formal DAs. The AAN also has a variety of downloadable SDM tools (www.aan.com/practice/patient-engagement/). The 74 neurology-related Choosing Wisely recommendations can help neurologists explain when a test or treatment is unlikely to help. 21 Organizations such as the Agency for Healthcare Research and Quality and Mayo Clinic's Center for Innovation develop more formal DAs with a particular emphasis on presenting infographics to represent risks, but few of these address neurologic topics. While tools help facilitate SDM, SDM can be achieved through discussion alone (e.g., table 1).
With direct-to-consumer advertising and patient Internet research, physicians face requests for tests or treatments in situations where there may be near-certainty that the request is not an appropriate approach.
CONCLUSION
There is an increasing emphasis on SDM that enables patients to make informed individualized health decisions targeting personal values and goals. Neurologists can adopt enhanced patientcentered practices by eliciting patients' values and goals, targeting discussion of evidence and options Table 2 Example of using clinical practice guidelines to facilitate shared decision-making Clinical practice guidelines provide a systematic review of the literature that provides neurologists with the information needed to guide patients through decisions.
Case 1
A 65-year-old man is due for routine colonoscopy screening. His cousin was recently diagnosed with colon cancer. He has a history of hypertension and hypercholesterolemia and a stroke 1 year ago attributed to intracranial large-artery atherosclerosis with mild residual left hemiparesis. His secondary stroke prevention includes aspirin 81 mg daily and his gastroenterologist asked him to discuss the colonoscopy plans with his neurologist.
Step 1: Solicitation of patients' values/goals The patient describes that he is very concerned about his own colon cancer risk given his cousin's recent diagnosis. At the same time, he lives with mild residual weakness and does not want to risk a recurrent vascular event.
The patient's neurologist reviews the 2013 American Academy of Neurology guideline 22 and based on that guideline, discusses the following concepts with the patient:
1. He is at a risk for recurrent stroke given his prior intracranial largeartery atherosclerotic event 2. He is having a screening colonoscopy and may not need polypectomy (which has a higher risk of bleeding)
3. The risk difference for aspirin-associated bleeding with polypectomy is approximately 2.0% based on the guideline review 4. Bleeding with polypectomy is likely to have lower morbidity than recurrent stroke
The neurologist also provides the patient guideline summary (www.aan. com/guidelines)
Step 3: Making the decision The patient decides he is willing to accept an increased bleeding risk to avoid recurrent stroke. He chooses to proceed with colonoscopy and possible polypectomy while continuing aspirin 325 mg daily.
Case 2
A 70-year-old woman was diagnosed with breast cancer requiring mastectomy. She had a small-vessel distribution ischemic stroke associated with uncontrolled hypertension 5 years previously. She has no residual deficits and diligently controls her vascular risk factors.
Step 1: Solicitation of patients' values/goals The patient's primary concern is having her breast cancer effectively treated, though she wants to minimize associated risks.
Her neurologist reviews the guideline and notes that there is minimal literature for the risks associated with aspirin continuation during more invasive procedures. The neurologist counsels the patient and her surgical oncologist that (1) the patient likely has a relatively low risk of recurrent stroke with brief aspirin cessation given her stroke type and good risk factor control and (2) there is little research on bleeding risks with aspirin during invasive procedures. The surgical oncologist provides evidence regarding bleeding risks with mastectomy.
Step 3: Making the decision Together, they choose to stop the aspirin 7 days before the surgery, having weighed the need for mastectomy, relatively low recurrent stroke risk with temporary aspirin cessation given the details of her stroke history, lack of data regarding bleeding risks with aspirin continuation during mastectomy, and risks associated with bleeding should it occur. The importance of restarting the aspirin postoperatively is stressed, and a specific start date is decide upon.
